Anne Schnitzler

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Optimized Metabolic Conditions Reveal the Adipogenic Competence of Wharton's Jelly MSCs: Insight from Literature Review and Experimental Validation.

Optimized Metabolic Conditions Reveal the Adipogenic Competence of Wharton's Jelly MSCs: Insight from Literature Review and Experimental Validation.

Journal: Stem cell reviews and reports
Published: June 07, 2026

The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.

The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.

Journal: The journal of pathology. Clinical research
Published: November 20, 2023

MSH3: a confirmed predisposing gene for adenomatous polyposis.

MSH3: a confirmed predisposing gene for adenomatous polyposis.

Journal: Journal of medical genetics
Published: April 25, 2023

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.

PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer.

Journal: Life science alliance
Published: February 23, 2023

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.

Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.

Journal: Nature communications
Published: August 11, 2022

Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening.

Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 19, 2022

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft.

Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft.

Journal: Cancers
Published: February 13, 2022

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.

Journal: Cancers
Published: September 24, 2020

MMP2 as an independent prognostic stratifier in oral cavity cancers.

MMP2 as an independent prognostic stratifier in oral cavity cancers.

Journal: Oncoimmunology
Published: September 16, 2020

Biopathological Significance of PIWI-piRNA Pathway Deregulation in Invasive Breast Carcinomas.

Biopathological Significance of PIWI-piRNA Pathway Deregulation in Invasive Breast Carcinomas.

Journal: Cancers
Published: August 21, 2020

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients.

Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients.

Journal: Scientific reports
Published: July 26, 2020

PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?

PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?

Journal: Clinics and research in hepatology and gastroenterology
Published: June 24, 2020
Showing 1-12 of 31

Last Updated: 09/26/2026